TY - JOUR
T1 - Unmasking senescence
T2 - context-dependent effects of SASP in cancer
AU - Faget, Douglas V.
AU - Ren, Qihao
AU - Stewart, Sheila A.
N1 - Funding Information:
The work was supported in part by the US Army Medical Research Acquisition Activity, from the awarding and administrating acquisition office at 820 Chandler Street, Fort Detrick MD 21702-5014; by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program, under Award W81XWH-16-1-0728; and by the US National Institutes of Health, Grant R01 AG059244 01A1. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense.
Publisher Copyright:
© 2019, The Publisher.
PY - 2019/8/1
Y1 - 2019/8/1
N2 - Cellular senescence plays a critical role in tumorigenesis. Once thought of as a tissue culture artefact by some researchers, senescence is now a major field of study. Although there are common molecular mechanisms that enforce the growth arrest that characterizes the phenotype, the impact of senescence is varied and can, in some instances, have opposite effects on tumorigenesis. It has become clearer that the cell of origin and the tissue in question dictate the impact of senescence on tumorigenesis. In this Review, we unravel this complexity by focusing on how senescence impacts tumorigenesis when it arises within incipient tumour cells versus stromal cells, and how these roles can change in different stages of disease progression. In addition, we highlight the diversity of the senescent phenotype and its functional output beyond growth arrest: the senescence-associated secretory phenotype (SASP). Fortunately, a number of new genetic and pharmacologic tools have been developed that are now allowing the senescence phenotype to be parsed further.
AB - Cellular senescence plays a critical role in tumorigenesis. Once thought of as a tissue culture artefact by some researchers, senescence is now a major field of study. Although there are common molecular mechanisms that enforce the growth arrest that characterizes the phenotype, the impact of senescence is varied and can, in some instances, have opposite effects on tumorigenesis. It has become clearer that the cell of origin and the tissue in question dictate the impact of senescence on tumorigenesis. In this Review, we unravel this complexity by focusing on how senescence impacts tumorigenesis when it arises within incipient tumour cells versus stromal cells, and how these roles can change in different stages of disease progression. In addition, we highlight the diversity of the senescent phenotype and its functional output beyond growth arrest: the senescence-associated secretory phenotype (SASP). Fortunately, a number of new genetic and pharmacologic tools have been developed that are now allowing the senescence phenotype to be parsed further.
UR - http://www.scopus.com/inward/record.url?scp=85068065547&partnerID=8YFLogxK
U2 - 10.1038/s41568-019-0156-2
DO - 10.1038/s41568-019-0156-2
M3 - Review article
C2 - 31235879
AN - SCOPUS:85068065547
SN - 1474-175X
VL - 19
SP - 439
EP - 453
JO - Nature Reviews Cancer
JF - Nature Reviews Cancer
IS - 8
ER -